Clinical trial to compare breast stimulation versus Pitocin for labor induction in term pregnancies

Induction of labor is a common obstetric procedure, often necessitated by various maternal or fetal conditions. The current standard of care frequently involves pharmacological agents like synthetic oxytocin (Pitocin), which, while effective, can lead to potential side effects such as uterine hyperstimulation, fetal distress, and increased need for epidural analgesia or C-sections. There is a clinical need for safer, less invasive, and more patient-centered methods for labor induction. Nipple stimulation is a non-pharmacological approach known to naturally release endogenous oxytocin, a hormone crucial for uterine contractions and labor progression. This study explores breast stimulation as a potentially gentler alternative to conventional pharmacological induction.

This is a randomized, unblinded clinical trial designed to compare breast pump nipple stimulation with standard Pitocin induction protocols. The study plans to enroll an estimated 48 term pregnant individuals requiring labor induction. Participants will be randomized into two arms: one receiving breast pump nipple stimulation and the other following the standard induction of labor protocol at KUMC. The standard protocol may include medications like misoprostol, mechanical methods such as a Foley catheter, and synthetic oxytocin (Pitocin). The primary outcome measures will focus on the efficacy of labor induction and patient acceptability, though specific endpoints like time to delivery or C-section rates are not detailed in the provided abstract.